Metraipolis › archive › dc_60cd998d56b6

Targeting MERTK tyrosine kinase: Virtual screening and molecular dynamics insights for anti-cancer drug development — Europe PMC PMID:41166341

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41166341
DOI
10.1371/journal.pone.0334106
License (as archived)
solo-consultazione
Archived
2026-11-08T23:08:35.919Z
SHA-256 of the archived text
5275c5e0a8a1d580f8a1c350abb65c74f1e5c4eba48aee987000d5102d544e24
Stable URL of this page
https://metraipolis.com/documento/dc_60cd998d56b6

How to cite

Targeting MERTK tyrosine kinase: Virtual screening and molecular dynamics insights for anti-cancer drug development — Europe PMC PMID:41166341 — Europe PMC (en), https://europepmc.org/article/MED/41166341 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_60cd998d56b6 (Metraipolis archive dc_60cd998d56b6, sha256 5275c5e0a8a1d580f8a1c350abb65c74f1e5c4eba48aee987000d5102d544e24)
BibTeX
@misc{dc60cd998d56b6,
  title = {Targeting MERTK tyrosine kinase: Virtual screening and molecular dynamics insights for anti-cancer drug development — Europe PMC PMID:41166341},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41166341},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_60cd998d56b6; sha256 5275c5e0a8a1d580f8a1c350abb65c74f1e5c4eba48aee987000d5102d544e24},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41166341. Agents can read the archived copy with the MCP tool read_document.